| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGIO | Common stock | Options Exercise | $181K | +20K | +16.97% | $9.05 | 138K | Jan 17, 2023 | Direct | F1 |
| transaction | AGIO | Common stock | Sale | -$547K | -19K | -13.76% | $28.82 | 119K | Jan 17, 2023 | Direct | F2, F3 |
| transaction | AGIO | Common stock | Sale | -$30.5K | -1.03K | -0.87% | $29.49 | 118K | Jan 17, 2023 | Direct | F2, F4 |
| holding | AGIO | Common stock | 271K | Jan 17, 2023 | See footnote | F5 | |||||
| holding | AGIO | Common stock | 79.1K | Jan 17, 2023 | See footnote | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGIO | Stock option (right to buy) | Options Exercise | $0 | -20K | -14.67% | $0.00 | 116K | Jan 17, 2023 | Common stock | 20K | $9.05 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F2 | This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F3 | The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.42 to $29.39. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $29.42 to $29.65. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F5 | Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary. |
| F6 | Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary. |
| F7 | This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. |